This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (144) Citing Articles via Google Scholar Google Scholar Articles by Goodwin, G. M. Search for Related Content PubMed PubMed Citation Articles by Goodwin, G. M. Social Bookmarking                   What's this?

Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology

For the Consensus Group of the British Association for Psychopharmacology

The British Association for Psychopharmacology guidelines specify the scope and target of treatment for bipolar disorder. They are based explicitly on the available evidence and presented, similar to previous Clinical Practice guidelines, as recommendations to aid clinical decision-making for practitioners. They may also serve as a source of information for patients and carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. The strength of supporting evidence was rated. The guidelines cover the diagnosis of bipolar disorder, clinical management and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.

Key Words: anticonvulsants • antidepressants • antipsychotics • bipolar disorder • CBT • depression • evidence-based guidelines • lithium • mania • mood stabilizers • treatment

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Franks, K. Macritchie, T Mahmood, and A. Young Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study J Psychopharmacol, June 1, 2008; 22(4): 452 - 456. [Abstract] [PDF]

				I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF]

				M. Tohen, C. L. Bowden, A. B. Smulevich, R. Bergstrom, T. Quinlan, O. Osuntokun, W. V. Wang, H. S. Oliff, F. Martenyi, L. A. Kryzhanovskaya, et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes The British Journal of Psychiatry, February 1, 2008; 192(2): 135 - 143. [Abstract] [Full Text] [PDF]

				C. Rao, A. Devanga, and J. R Geddes Antidepressants are not an effective adjunct to mood stabilisers for bipolar depression Evid. Based Ment. Health, November 1, 2007; 10(4): 109 - 109. [Full Text] [PDF]

				G. M. Goodwin and J. R. Geddes What is the heartland of psychiatry? The British Journal of Psychiatry, September 1, 2007; 191(3): 189 - 191. [Abstract] [Full Text] [PDF]

				J. McKendrick, K.H. Cerri, A. LLoyd, A. D'AusiLio, S. Dando, and C. Chinn Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom J Psychopharmacol, August 1, 2007; 21(6): 588 - 596. [Abstract] [PDF]

				H. Scherk, F. G. Pajonk, and S. Leucht Second-Generation Antipsychotic Agents in the Treatment of Acute Mania: A Systematic Review and Meta-analysis of Randomized Controlled Trials Arch Gen Psychiatry, April 1, 2007; 64(4): 442 - 455. [Abstract] [Full Text] [PDF]

				A. Streeruwitz, T. R. E. Barnes, J. Fehler, R. Ohlsen, and V. A. Curtis Pharmacological management of acute mania - does current prescribing practice reflect treatment guidelines? J Psychopharmacol, March 1, 2007; 21(2): 206 - 209. [Abstract] [PDF]

				J. Scott, E. Paykel, R. Morriss, R. Bentall, P. Kinderman, T. Johnson, R. Abbott, and H. Hayhurst Cognitive-Behavioural Therapy for Severe and Recurrent Bipolar Disorders: Randomised Controlled Trial Focus, January 1, 2007; 5(1): 64 - 72. [Abstract] [Full Text] [PDF]

				D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology J Psychopharmacol, January 1, 2007; 21(1): 10 - 41. [Abstract] [PDF]

				A. Burns and J. O'Brien Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol, November 1, 2006; 20(6): 732 - 755. [Abstract] [PDF]

				P. Keown, H. Mcallister-Williams, and A. Young A case of pancytopenia J Psychopharmacol, September 1, 2006; 20(5): 690 - 692. [Abstract] [PDF]

				G. E. Simon, E. J. Ludman, M. S. Bauer, J. Unutzer, and B. Operskalski Long-term Effectiveness and Cost of a Systematic Care Program for Bipolar Disorder. Arch Gen Psychiatry, May 1, 2006; 63(5): 500 - 508. [Abstract] [Full Text] [PDF]

				J. SCOTT, E. PAYKEL, R. MORRISS, R. BENTALL, P. KINDERMAN, T. JOHNSON, R. ABBOTT, and H. HAYHURST Cognitive-behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial The British Journal of Psychiatry, April 1, 2006; 188(4): 313 - 320. [Abstract] [Full Text] [PDF]

				L. N Nguyen and S. K Guthrie Risperidone Treatment of Bipolar Mania Ann. Pharmacother., April 1, 2006; 40(4): 674 - 682. [Abstract] [Full Text] [PDF]

				R. H. McAllister-Williams Relapse prevention in bipolar disorder: a critical review of current guidelines. J Psychopharmacol, March 1, 2006; 20(2 Suppl): 12 - 16. [Abstract] [PDF]

				J. Cookson and B. Elliott The use of anticonvulsants in the aftermath of mania. J Psychopharmacol, March 1, 2006; 20(2_suppl): 23 - 30. [Abstract] [PDF]

				J. Geddes Bipolar disorder--services need to catch up with rapidly developing evidence base BMJ, January 7, 2006; 332(7532): 32 - 33. [Full Text] [PDF]

				A. Menon, R. H. M. Williams, and S. Watson Increased libido associated with quetiapine J Psychopharmacol, January 1, 2006; 20(1): 125 - 127. [Abstract] [PDF]

				D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol, November 1, 2005; 19(6): 567 - 596. [Abstract] [PDF]

				M. Olfson, A. K. Das, M. J. Gameroff, D. Pilowsky, A. Feder, R. Gross, R. Lantigua, S. Shea, and M. M. Weissman Bipolar Depression in a Low-Income Primary Care Clinic Am J Psychiatry, November 1, 2005; 162(11): 2146 - 2151. [Abstract] [Full Text] [PDF]

				R. Macpherson, R. Dix, and S. Morgan A growing evidence base for management guidelines: REVISITING... GUIDELINES FOR THE MANAGEMENT OF ACUTELY DISTURBED PSYCHIATRIC PATIENTS Advan. Psychiatr. Treat., November 1, 2005; 11(6): 404 - 415. [Abstract] [Full Text] [PDF]

				L. Citrome and D. Yeomans Do guidelines for severe mental illness promote physical health and well-being? J Psychopharmacol, November 1, 2005; 19(6_suppl): 102 - 109. [Abstract] [PDF]

				A. Cipriani, H. Pretty, K. Hawton, and J. R. Geddes Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials Am J Psychiatry, October 1, 2005; 162(10): 1805 - 1819. [Abstract] [Full Text] [PDF]

				H. J. GIJSMAN, J. R. GEDDES, J. M. RENDELL, G. M. GOODWIN, and W. A. NOLEN Dr. Gijsman and Colleagues Reply Am J Psychiatry, August 1, 2005; 162(8): 1547 - 1548. [Full Text] [PDF]

				J. R. Calabrese, P. E. Keck Jr., W. Macfadden, M. Minkwitz, T. A. Ketter, R. H. Weisler, A. J. Cutler, R. McCoy, E. Wilson, J. Mullen, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression Am J Psychiatry, July 1, 2005; 162(7): 1351 - 1360. [Abstract] [Full Text] [PDF]

				Drug treatments for bipolar disorder: 2 - Maintenance, prevention and special situations DTB, May 1, 2005; 43(5): 33 - 37. [Abstract] [Full Text] [PDF]

				C. H. Ashton, P. B. Moore, P. Gallagher, and A. H. Young Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential J Psychopharmacol, May 1, 2005; 19(3): 293 - 300. [Abstract] [PDF]

				G. Goodwin and A. H. Young Using guidelines in real clinical situations: clozapine and breast feeding in bipolar disorder J Psychopharmacol, May 1, 2005; 19(3): 317 - 318. [PDF]

				Drug treatments for bipolar disorder: 1 - Acute manic or depressive DTB, April 1, 2005; 43(4): 28 - 32. [Abstract] [Full Text] [PDF]

				A. I. F. Scott College guidelines on electroconvulsive therapy: an update for prescribers Advan. Psychiatr. Treat., March 1, 2005; 11(2): 150 - 156. [Abstract] [Full Text] [PDF]

				P. J. Cowen New drugs, old problems: REVISITING... PHARMACOLOGICAL MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION Advan. Psychiatr. Treat., January 1, 2005; 11(1): 19 - 27. [Abstract] [Full Text] [PDF]

				S. Frangou Advancing the pharmacological treatment of bipolar depression Advan. Psychiatr. Treat., January 1, 2005; 11(1): 28 - 37. [Abstract] [Full Text] [PDF]

				G. E. JESS, D. J. SMITH, C. MacKENZIE, and C. CRAWFORD Carbamazepine and Rebound Mania Am J Psychiatry, November 1, 2004; 161(11): 2132 - 2133. [Full Text] [PDF]

				M. Sajatovic, F. C. Blow, R. V. Ignacio, and H. C. Kales Age-Related Modifiers of Clinical Presentation and Health Service Use Among Veterans With Bipolar Disorder Psychiatr Serv, September 1, 2004; 55(9): 1014 - 1021. [Abstract] [Full Text] [PDF]

				H. J. Gijsman, J. R. Geddes, J. M. Rendell, W. A. Nolen, and G. M. Goodwin Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials Am J Psychiatry, September 1, 2004; 161(9): 1537 - 1547. [Abstract] [Full Text] [PDF]

				A. R. Lingford-Hughes, S. Welch, and D. J. Nutt Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, September 1, 2004; 18(3): 293 - 335. [PDF]

				I. M. Anderson, P. M. Haddad, and I. Chaudhry Changes in Pharmacological treatment for Bipolar Disorder Over Time in Manchester: A Comparison with Lloyd et al. (2003) J Psychopharmacol, September 1, 2004; 18(3): 441 - 444. [PDF]

				J. E. Bailey The Application of Good Clinical Practice to Challenge Tests J Psychopharmacol, March 1, 2004; 18(1): 16 - 16. [PDF]

				Z. Bhagwagar and G. M. Goodwin Bipolar-spectrum disorders: an epidemic unseen, invisible or unreal? Advan. Psychiatr. Treat., January 1, 2004; 10(1): 1 - 3. [Full Text] [PDF]

				J. Geddes Prodromal symptoms may be identified by people with bipolar or unipolar depression Evid. Based Ment. Health, November 1, 2003; 6(4): 105 - 105. [Full Text] [PDF]